Clinical Associate Professor in the Division of Pharmacotherapy Dr. Kirk Evoy spoke to CNN about the possibilities of making naloxone, a medication used to reverse or reduce the effects of opioids, available over-the-counter.
P4 students, Megan Yeung, Kami Johnston and Morgan Murchison co-author a peer-reviewed blog in Pulses encouraging educators to adapt to reflect the specific needs of people who use drugs and patients with substance use disorders. This blog also highlights UT Pharmacy as a U.S. leader in substance use disorder and harm reduction education for Pharm.D. students.
Tara Law from Time writes about how few pharmacies carry buprenorphine, a life-saving drug to help treat opioid use disorder (OUD). Lucas Hill, Pharm.D., BCACP, director of the college's Pharmacy Addictions Research & Medicine (PhARM) program, offers his insight on the issue, and how the DEA's crackdown of the drug puts OUD patients at risk.
A paper from UT College of Pharmacy researchers was awarded the 2021 Outstanding Paper of the Year from the American College of Clinical Pharmacy (ACCP) Ambulatory Care Practice Research Network. The paper investigates the availability of buprenorphine and naloxone in Texas to treat opioid use disorder.
The college was awarded the American Association of Colleges of Pharmacy’s 2020 Lawrence C. Weaver Transformative Community Service Award. This video outlining the community service efforts of the college was included in the virtual ceremony on Wednesday, July 21, 2021 during AACP's annual meeting.
The American Association of Colleges of Pharmacy (AACP) announced the winners of its Award for Excellence in Experiential Education and The University of Texas at Austin College of Pharmacy experiential program team was included. The award is in recognition of dedication and innovations to the experiential curriculum in 2020-2021.